Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Appointed director
Inv. presentation
Quarterly results
Amneal Pharmaceuticals, Inc. (AMRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/04/2023 8-K Quarterly results
Docs: "AMNEAL REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS"
05/19/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Notice of Pendency of Settlement of Derivative Action"
05/12/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/05/2023 8-K Quarterly results
Docs: "AMNEAL REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS"
04/17/2023 8-K Quarterly results
03/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/24/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/02/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
03/02/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
03/02/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "AMNEAL REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS"
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 8.6% stake in Amneal Pharmaceuticals Inc.
01/10/2023 8-K Quarterly results
12/14/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/07/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/04/2022 8-K Quarterly results
09/06/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Employment Agreement dated September 1, 2022, by and between Amneal Pharmaceuticals, Inc. and Gustavo Pesquin",
"Amneal Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer - Specialty September 6, 2022"
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/05/2022 8-K Quarterly results
08/03/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Amneal Appoints Deborah M. Autor to Board of Directors"
07/19/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
05/06/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/04/2022 8-K Quarterly results
03/25/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/25/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/16/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/02/2022 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy